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Abstract: Introduction: The new coronavirus (SARS-CoV-2), has infected more than 23 million individuals to date 
and has resulted in more than 800,000 deaths worldwide. The rapid spread of SARS-CoV-2 and its variants 
requires the urgent development of accurate diagnostic methods, effective treatments, and vaccines. The 
recommendations are also related to the Expert Consensus for Clinical Management of Covid-19, at the 
headquarters of the Pan American Health Organization / World Health Organization (PAHO / WHO) in Brasilia 
(Brazil). Objective: To gather the main pathophysiological considerations of COVID-19, as well as the actions of 
investigation, management, and adoption of preventive measures against the complications caused by SARS-CoV-2 
in the emergency of hospitals. Methods: This study followed an integrative review model based on the systematic 
review model. The search for the articles occurred in the databases WHO, PAHO, Ministry of Health, PubMed, 
Embase, Ovid, Cochrane Library, and Google Scholar. The quality of the studies was based on the GRADE 
instrument. The risk of bias was analyzed according to the Cochrane instrument. Results and Conclusion: A total of 
58 clinical studies were recruited and submitted to eligibility analysis and, after that, 26 studies were selected, 
including official public health guidelines and regulations. To the published articles, studies of high to medium 
quality and with risks of bias were selected that do not compromise the scientific basis of the studies. Based on the 
main literary findings, as well as the main public health guidelines published in the world, patients with COVID-19 
may present respiratory syndromes very similar to the common influenza virus (influenza), being a challenge for 
early detection during screening. in emergency departments. According to the official health agencies of Brazil 
(Ministry of Health) and the world (WHO/PAHO) and their regulations, it was defined that the clinical criteria for 
hospital discharge should take into account the improvement of the clinical picture, the absence of tachydyspnea 
and hypoxia, the absence of O2 supplementation for at least 24 hours, hemodynamic stability, good oral 
acceptance and absence of fever. 
Keywords: Pandemia, COVID-19, SARS-CoV-2, SARS, Prevention, Emergency department 
 
1. Introduction 
 In the COVID-19 pandemic scenario, the new 
coronavirus (SARS-CoV-2), has infected more than 23 
million individuals to date and has resulted in more 
than 800,000 deaths worldwide [1,2]. In this sense, 
the rapid spread of SARS-CoV-2 and its variants 
requires urgent development of accurate diagnostic 
methods, effective treatments, and vaccines [3]. 
In Brazil, on January 22, 2020, the Public 
Health Emergency Operations Center for COVID-19 
was activated, a strategy provided for in the National 
Public Health Emergency Response Plan of the Ministry 
of Health (MS) [4]. Thus, the Ministry of Health 
established a structured document based on existing 
actions (to influenza) for notification, registration, 
investigation, management, and adoption of 
preventive measures [5-7]. In addition, the 
recommendations are also related to the Covid-19 
Expert Consensus on Clinical Management at the 
headquarters of the Pan American Health Organization 
/ World Health Organization (PAHO / WHO) in Brasilia 
(Brazil) [8,9]. 
In this context, Severe Acute Respiratory 
Syndrome (SARS) is a severe acute respiratory disease 
caused by SARS-CoV-2 [10]. This was initially detected 
in Guangdong Province, China, in November 2002 and 
subsequently spread to more than 30 countries [11], is 
transmitted from person to person by close personal 
contact. The communicability period of COVID-19 
varies, but it is usually 2 to 14 days, and the main 
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signs and symptoms of COVID-19 are high 
temperatures, strong and consistent cough, and severe 
breathing problems [12]. 
In this context, complications result in severe 
inflammation of the lungs, and organ malfunction 
occurs in patients with comorbidities and health 
problems, especially diabetes, heart disease, and 
obesity. There is currently no cure for COVID-19. The 
world is faced with the containment of the spread of 
infection, highlighting that careful hand washing, use 
of hand sanitizer alcohol, frequent cleaning of 
surfaces, strict adherence to social distance, regular 
respiratory hygiene, use of protective face masks, tests 
Frequent self-isolation, quarantine and rigorous 
contact tracking will help prevent the spread and 
control the transmission of the viral pathogen [12]. 
In this scenario, the present study aimed to 
gather the main pathophysiological considerations of 
COVID-19, as well as the actions of investigation, 
management, and adoption of preventive measures 
against complications caused by SARS-CoV-2 in the 
emergency of hospitals. 
 
2. Methods 
2.1. Study Design 
This study followed an integrative review 
model based on the systematic review model, 
following the rules of the PRISMA Platform 




2.2. Search Strategy and Information 
Sources 
 The search for the articles occurred in the 
databases WHO, PAHO, Ministry of Health, PubMed, 
Embase, Ovid, Cochrane Library, and Google Scholar, 
following the search for MeSH Terms: Pandemia. 
COVID-19. SARS-CoV-2. Severe Acute Respiratory 
Syndrome. Acute Respiratory Distress Syndrome. 
Prevention. Emergency department, and use of 
Booleans "and" between mesh terms and "or" among 
historical findings. 
 
2.3. Study Quality and Bias Risk 
The quality of the studies was based on the 
GRADE instrument [14]. The quality of the evidence 
was classified as high, moderate, low, or very low, 
according to the risk of bias, clarity of comparisons, 
precision, and consistency of the analyzes. The 
randomized controlled clinical trials (RCTs) have given 
the highest preference, as it provides high scientific 
evidence. The risk of bias was analyzed according to 
the Cochrane instrument [15]. 
 
3. Results and Discussion  
A total of 133 studies were recruited and 
submitted to eligibility analysis and, after that, 29 
studies were selected, including official public health 
guidelines and regulations. To the published articles, 
studies of high to medium quality and with risks of bias 
were selected that do not compromise the scientific 
basis of the studies (Figure 1). 
Figure 1. Eligibility of studies. 
 
3.1 General Guidelines Information 
Based on the main literary findings, as well as 
the main public health guidelines published in the 
world, patients with COVID-19 may present respiratory 
syndromes very similar to the common influenza virus 
(influenza), being a challenge for early detection 
during screening. in emergency departments. One 
study investigated a total of 1,841 cases with 
respiratory syndromes. Among these, 70 cases of 
COVID-19 were subsequently confirmed. The majority 
(84.2%) were detected in emergency screening 
because they met the criteria for a suspected case. Of 
these, 34 met the official selection criteria; another 25 
were detected by the broader internal screening 
criteria. Over the 12 weeks, the cumulative sensitivity 
of the internal screening criteria was 84.3%, while the 
sensitivity of the official screening criteria was 48.6%. 
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There were no cases of nosocomial transmission of 
exposure in the emergency department. Therefore, 
frontline physicians need to have room for maneuver 
to decide on the disposition of cases based on clinical 
suspicion during an ongoing outbreak of COVID-19, 
and the use of appropriate PPE is essential to minimize 
nosocomial transmission [16]. 
In this context, one of the main concerns of 
hospitals is to limit the spread of SARS-CoV-2 in 
hospital environments. As the virus spreads mainly 
through respiratory droplets, it is imperative to 
redouble the care with the use of non-invasive 
ventilation (NIV), high flow nasal cannula (HFNC), and 
awake pronation (not intubated). As a corollary to this, 
patients who had increasing oxygen needs were 
intubated and mechanically ventilated to avoid 
exposure to aerosol-generating procedures. However, 
doctors realized that the mortality of invasively 
ventilated patients was high and it was not easy to 
extubate many of these patients [17]. 
In the SARS scenario, supplemental oxygen 
therapy must be administered immediately to patients 
with breathing difficulties, hypoxemia, or shock with a 
SpO2 target > 94% [18]. Adults with obstruction or 
absence of breathing, severe respiratory distress, 
central cyanosis, shock, coma, or seizures must receive 
airway management and oxygen therapy during 
resuscitation to achieve SpO2 ≥ 94%, it is important to 
start oxygen therapy at 5 L/min and assess flow rates 
to achieve the SpO2 target ≥ 93% during resuscitation, 
or use a face mask with a reservoir bag (10-15 L/min) 
if the patient is in critical condition [18]. 
After patient stabilization, the target is SpO2 > 
90% in adults (without pregnancy) and ≥ 92% -95% 
in pregnant patients. In children with emergency signs 
(obstruction or shortness of breath, severe respiratory 
distress, central cyanosis, shock, coma, or seizures) 
they must receive airway management and oxygen 
therapy during resuscitation to achieve SpO2 ≥ 94%, 
otherwise, the goal is SpO2 ≥ 90%. The use of a nasal 
cannula is preferable in young children, as they can be 
better tolerated [19]. 
Still, it is indicated to use conservative 
treatment of intravenous fluids with caution in patients 
with SARS when there is no evidence of shock [20], as 
aggressive resuscitation of fluids can worsen 
oxygenation, especially in environments where the 
availability of mechanical ventilation is limited. It is 
also indicated to administer antibiotics within one hour 
of the initial assessment of patients with sepsis, as well 
as to collect cultures within one hour before starting 
the antibiotic [21,22]. In addition, it has been indicated 
not to routinely administer systemic corticosteroids for 
the treatment of viral pneumonia or SARS outside 
clinical trials, except for other reasons [23]. Another 
important indication is the performance of laboratory 
tests and electrocardiogram (ECG) at the patient's 
admission, to monitor complications, such as acute 
liver injury, acute kidney injury, acute cardiac injury, or 
shock [24]. 
 
3.2 Hypoxemic Respiratory Failure 
Severe hypoxemic respiratory failure occurs 
when a patient with difficulty breathing has failed 
standard oxygen therapy. Advanced oxygen/ventilation 
support must be provided. If these patients require O2 
via a nasal catheter greater than 5 liters/minute to 
sustain SpO2> 93% and/or have a respiratory rate> 28 
irpm or CO2 retention (PaCO2> 50 mmHg and/or pH 
<7.25) they should be intubated and mechanically 
ventilated immediately [25]. 
Also, the procedure with endotracheal 
intubation is necessary if the patient does not respond 
to oxygen therapy. However, it is necessary to 
redouble the care in patients such as small children or 
people who are obese or are pregnant as they can 
quickly desaturate during intubation, requiring pre-
oxygenation with an inspired fraction of oxygen (FiO2) 
at 100% for 5 minutes, for using a face mask with a 
reservoir bag [26]. 
Furthermore, patients submitted to invasive 
mechanical protective ventilation may be ventilated in 
controlled volume or pressure mode with a tidal 
volume equal to 6 mL/kg of predicted weight and 
plateau pressure less than 30 cmH2O, with distention 
pressure or driving pressure (= plateau pressure minus 
PEEP) less than 15 cmH2O [5]. It is also necessary to 
adjust the smallest enough PEEP to maintain SpO2 
between 90-95%, with FiO2 <60% (using ARDSNet's 
PEEP / FIO2 table for low PEEP. It was found that the 
use of higher PEEP proved to be causing pulmonary 
hyperinflation and worsening of the evolution of part 
of the patients with COVID-19 [5]. 
Also, the prone position can improve 
oxygenation, but patient safety must be guaranteed. 
In cases of PaO2 / FIO2 less than 150, with adequate 
PEEP according to the PEEP / FIO2 table, it is 
suggested to use protective ventilation by placing the 
patient in a prone position for at least 16 hours. To 
perform the rotation and to maintain the patient in a 
prone position, adequate sedoanalgesia should be 
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provided and, if necessary, curarization. The patient 
can remain supine if, after being "unresponsive", he 
remains with PaO2 / FIO2 > 150. Otherwise, one can 
consider placing the patient in a prone position again 
[5]. 
 
3.3 Interventions to Avoid Complications 
Severe hypoxemic respiratory failure occurs 
when a patient with difficulty breathing has failed 
standard oxygen therapy. Advanced oxygen/ventilation 
support must be provided. If these patients require O2 
via a nasal catheter greater than 5 liters/minute to 
sustain SpO2> 93% and/or have a respiratory rate> 28 
irpm or CO2 retention (PaCO2> 50 mmHg and/or pH 
<7.25) they should be intubated and mechanically 
ventilated immediately [25]. 
In critically ill patients, NIV, mechanical 
ventilation, or extracorporeal life support is considered 
if necessary [27]. In this sense, the main treatments 
are highlighted as hemodynamic management, with 
vasopressor support, nutritional support, blood glucose 
control, prompt assessment and treatment of 
nosocomial or concomitant bacterial pneumonia, 
prophylaxis against deep vein thrombosis and 
gastrointestinal bleeding, and proper patient 
positioning to assist in oxygenation and ventilation 
(Table 1). 
In this sense, data from China and Italy 
suggest that patients with hypoxemic COVID-19 
respond well to PEEP, indicating a crucial role of NIV 
as a therapeutic and palliative measure to prevent 
intubation. Retrospective analyzes in China indicate 
that up to 30% of the admitted patients needed NIV, 
and in Italy, they indicate values close to 31% [27]. In 
addition, a retrospective study of 1,591 consecutive 
laboratory-confirmed patients with COVID-19 and 
referred for admission to the ICU in Milan in Italy 
showed that the majority were older men, a large 
proportion required mechanical ventilation and high 
levels of PEEP, and ICU mortality was 26% [28]. 
Also, another retrospective study looked at the 
relationship between obesity and SARS-CoV-2, looking 
at the relationship between clinical characteristics, 
including body mass index (BMI) and the need for 
invasive mechanical ventilation (IMV) in 124 
consecutive patients admitted to intensive therapy by 
SARS-CoV-2, in a single French center. 
 
Table 1. Interventions to avoid patient complications. 
Interventions Management 
Reduction of invasive 
mechanical ventilation 
❖ Daily assessment of spontaneous breathing capacity; 
❖ Minimize sedation, continuous or intermittent; 
Reduce incidence of 
ventilator-associated 
pneumonia 
❖ Prefer oral intubation to nasal intubation; 
❖ Keep the patient in a semi-reclining position (head elevated between 30 ° and 
45 °); 
❖ Use closed suction system; 
❖ Use a new ventilation circuit for each patient; 
❖ Change the humidifier when there is a malfunction, following the manufacturer's 
recommendations; 
❖ Reduce the time of invasive mechanical ventilation. 
Reduce incidence of 
venous thromboembolism 
❖ Use pharmacological prophylaxis in patients without contraindications. 
Reduce incidence of blood 
catheter infection 
❖ Create a reminder of the date of insertion of the catheter and its removal when 
it is no longer needed. 
Minimize the occurrence of 
decubitus ulcers 
❖ Promote a change of position every two hours 
Source: World Health Organization (adapted) [1] 
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Obesity (BMI> 30 kg/m2) and severe obesity 
(BMI> 35 kg / m2) were present in 47.6% and 28.2% 
of cases, respectively. Overall, 85 patients (68.6%) 
required IMV. The proportion of patients who needed 
IMV increased with the BMI categories (p <0.01, chi-
square test for trend), and was higher in patients with 
a BMI> 35 kg / m2 (85.7%). In multivariate logistic 
regression, the need for IMV was significantly 
associated with male gender (p <0.05) and BMI (p 
<0.05), regardless of age, diabetes, and hypertension. 
The proportion ratio for IMV in patients with a BMI> 
35 kg / m2 versus patients with a BMI <25 kg / m2 
was 7.36. Therefore, there was a high frequency of 
obesity among patients admitted to intensive care with 
COVID-19. The severity of the disease worsened with 
an increase in BMI. Thus, obesity is a risk factor for 
the severity of SARS-CoV-2, requiring greater attention 
to preventive measures in susceptible individuals [29]. 
In this context, it is recommended to expand the 
storage of NIV devices and ventilators in hospitals in 
general. Still, it is strongly recommended to provide 
part of the emergency and inpatient units for patients 
with COVID-19 [30]. 
In addition, a study provided 
recommendations for a systematic approach to the 
care of patients with AMI during the COVID-19 
pandemic. The cardiovascular manifestations of 
COVID-19 are complex with patients who have AMI, 
myocarditis simulating a presentation of ST-elevation 
myocardial infarction (STEMI), stress cardiomyopathy, 
non-ischemic cardiomyopathy, coronary spasm, or 
nonspecific myocardial injury and the prevalence of 
COVID -19 remains unknown with risk of 
asymptomatic dissemination. During the COVID-19 
pandemic, primary PCI remains the standard of care 
for patients with STEMI in PCI-capable hospitals, when 
it can be delivered promptly, with a team of specialists 
equipped with PPE in a dedicated CCL room [31]. 
In this context, about 20% of patients with 
COVID-19 have severe coagulation abnormalities, 
which can occur in almost all severe cases. 
Concomitant venous thromboembolism (VTE) has been 
frequently reported in cases of COVID-19. Experts and 
doctors from China and Europe have developed a 
consensus-based on evidence and opinions on the 
prophylaxis and management of VTE associated with 
COVID-19. This statement is aimed at physicians 
treating COVID-19 and provides practical 
recommendations in detailed situations, for example, 
how to choose thromboprophylaxis measures for 
patients with different severity of the disease and risk 
of bleeding, or what type of anticoagulant should be 
prescribed. With limited experience in VTE associated 
with COVID19 [32]. 
 
Conclusion 
According to the official health agencies of 
Brazil (Ministry of Health) and the world (WHO/PAHO) 
and their regulations, it is recommended that patients 
diagnosed with SARS be hospitalized, and the cases 
identified with the symptoms of severity hospitalized in 
an intensive care bed. It was defined that the clinical 
criteria for hospital discharge should take into account 
the improvement of the clinical picture, the absence of 
tachydyspnea and hypoxia, the absence of O2 
supplementation for at least 24 hours, the 
hemodynamic stability, the good acceptance of the 
oral route and the absence of fever. Prophylactic use 
of antibiotics was not recommended, but use should 
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